Strategy for antimicrobial resistance surveillance in Australia

Abstract

Disclaimer: The views expressed in this item are those of the individual authors, and do not necessarily represent the views of the Communicable Diseases Intelligence journal or the Australian Centre for Disease Control. While this Policy and Guidelines item was drafted with consideration to the then-available information on the condition(s) addressed within, it may not be complete and may not represent the currently understood best practice for the referenced condition(s). Readers are advised to refer to the most recent guidance on this matter, where such guidance exists and where its authoritativeness can be established. These guidelines do not replace the need for clinical judgment to be exercised for each individual circumstance, nor the necessity for expert advice to be obtained as appropriate.   

The importance of surveillance* in combating and managing antimicrobial† resistance (AMR) is recognised as an important component of the World Health Organization (WHO) Global Strategy for Containment of Antimicrobial Resistance, 2001. There is good evidence that surveillance is a cost-effective infection control strategy.^1,2 Appropriate surveillance provides vital information for the targeting of interventions, and measures success or failure of these interventions. Surveillance enables early detection and intervention, and can therefore reduce the extent and severity of outbreaks. This in turn should reduce infection-related costs, making funds available for other healthcare activities. Short-term investment, therefore, leads to longer-term gains and overall savings.